The ‘comeback’ of Selinexor: From toxic to tolerable
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference12 articles.
1. Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
2. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management;Rajkumar;Am J Hematol,2020
3. Multiple myeloma current treatment algorithms;Rajkumar;Blood Cancer J,2020
4. Targeting Nuclear Export Proteins in Multiple Myeloma Therapy;Theodoropoulos;Target Oncol,2020
5. Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial;Kalakonda;Lancet Haematol,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Selinexor targeting XPO1 promotes PEG3 nuclear accumulation and suppresses cholangiocarcinoma progression;Cancer Chemotherapy and Pharmacology;2024-08-05
2. The effect of selinexor on prostaglandin synthesis in virus-positive Merkel cell carcinoma cell lines;Archives of Dermatological Research;2024-06-01
3. A novel application of XPO1 inhibition for the treatment of myelofibrosis;Blood Neoplasia;2024-06
4. Multiplexed cellular profiling identifies an organoselenium compound as an inhibitor of CRM1 ‐mediated nuclear export;Traffic;2022-11-29
5. Efficacy and safety of selinexor-based regimens for relapsed/refractory multiple myeloma: a systematic review of literature;Annals of Hematology;2022-10-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3